Form 4 · Filed May 20, 2026, 08:07 PM UTC
BCAX/Bicara Therapeutics Inc.
Mazumdar Claire — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 18, 2026 | M | other | 15,000 | $4 | $56,847 | 377,152 |
| May 18, 2026 | S | sell | 12,022 | $20 | $239,982 | 365,130 |
| May 18, 2026 | S | sell | 2,978 | $20 | $60,597 | 362,152 |
| May 18, 2026 | M | other | 15,000 | — | — | 146,107 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-036885